1-3 of 3
Jane P. Hasselby
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study

Alice Markussen, Julia S. Johansen, Finn O. Larsen, Susann Theile, Jane P. Hasselby, Gro L. Willemoe, Torben Lorentzen, Kasper Madsen, Estrid Høgdall, Tim S. Poulsen, Eva E. Wilken, Poul Geertsen, Claus P. Behrens, Inge M. Svane, Dorte Nielsen, Inna M. Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (16): 3428–3437.
https://doi.org/10.1158/1078-0432.CCR-24-0286
Published: 15 August 2024
View article titled, Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study
Open the PDF for Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study in another window
Includes: Supplementary data
Journal Articles

Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification

Sidsel C. Lindgaard, Zsófia Sztupinszki, Emil Maag, Inna M. Chen, Astrid Z. Johansen, Benny V. Jensen, Stig E. Bojesen, Dorte L. Nielsen, Carsten P. Hansen, Jane P. Hasselby, Kaspar R. Nielsen, Zoltan Szallasi, Julia S. Johansen
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (9): 2592–2603.
https://doi.org/10.1158/1078-0432.CCR-20-4215
Published: 01 May 2021
View article titled, Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification
Open the PDF for Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification in another window
Includes: Supplementary data
Journal Articles

Copenhagen Prospective Personalized Oncology (CoPPO)—Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials

Ida Viller Tuxen, Kristoffer Staal Rohrberg, Olga Oestrup, Lise Barlebo Ahlborn, Ane Yde Schmidt, Iben Spanggaard, Jane P. Hasselby, Eric Santoni-Rugiu, Christina Westmose Yde, Morten Mau-Sørensen, Finn Cilius Nielsen, Ulrik Lassen
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (4): 1239–1247.
https://doi.org/10.1158/1078-0432.CCR-18-1780
Published: 15 February 2019
View article titled, Copenhagen Prospective Personalized Oncology (CoPPO)—Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials
Open the PDF for Copenhagen Prospective Personalized Oncology (CoPPO)—Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials in another window
Includes: Supplementary data